$350 Million is the total value of Nextech Invest Ltd.'s 14 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 27.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RVMD | Buy | REVOLUTION MEDICINES INC | $100,497,000 | +34.5% | 3,939,529 | +32.7% | 28.69% | +45.8% |
| EQRX INC | $54,121,000 | -39.4% | 13,104,424 | 0.0% | 15.45% | -34.4% | ||
| KNTE | KINNATE BIOPHARMA INC | $33,873,000 | -36.5% | 3,008,243 | 0.0% | 9.67% | -31.1% | |
| PMVP | PMV PHARMACEUTICALS INC | $28,853,000 | -9.9% | 1,385,807 | 0.0% | 8.24% | -2.3% | |
| TYRA BIOSCIENCES INC | $26,949,000 | -24.0% | 2,518,582 | 0.0% | 7.69% | -17.6% | ||
| ARVN | ARVINAS INC | $19,332,000 | -18.1% | 287,251 | 0.0% | 5.52% | -11.2% | |
| MRTX | New | MIRATI THERAPEUTICS INC | $14,249,000 | – | 173,300 | +100.0% | 4.07% | – |
| RLAY | New | RELAY THERAPEUTICS INC | $14,231,000 | – | 475,485 | +100.0% | 4.06% | – |
| CGEM | CULLINAN ONCOLOGY INC | $12,785,000 | -32.1% | 1,221,145 | 0.0% | 3.65% | -26.5% | |
| BPMC | New | BLUEPRINT MEDICINES CORP | $12,024,000 | – | 188,228 | +100.0% | 3.43% | – |
| KRON | KRONOS BIO INC | $10,495,000 | -46.8% | 1,451,537 | 0.0% | 3.00% | -42.4% | |
| CCCC | C4 THERAPEUTICS INC | $9,118,000 | -24.7% | 375,857 | 0.0% | 2.60% | -18.4% | |
| THESEUS PHARMACEUTICALS INC | $7,048,000 | -9.1% | 611,310 | 0.0% | 2.01% | -1.5% | ||
| SBTX | SILVERBACK THERAPEUTICS INC | $6,704,000 | -47.3% | 1,910,029 | 0.0% | 1.91% | -42.9% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| REVOLUTION MEDICINES INC | 8 | Q3 2023 | 44.0% |
| EQRX INC | 8 | Q3 2023 | 23.5% |
| TYRA BIOSCIENCES INC | 8 | Q3 2023 | 16.9% |
| KINNATE BIOPHARMA INC | 8 | Q3 2023 | 14.0% |
| CULLINAN ONCOLOGY INC | 8 | Q3 2023 | 5.3% |
| PMV PHARMACEUTICALS INC | 8 | Q3 2023 | 8.4% |
| ARVINAS INC | 8 | Q3 2023 | 6.2% |
| SILVERBACK THERAPEUTICS INC | 8 | Q3 2023 | 6.5% |
| KRONOS BIO INC | 8 | Q3 2023 | 5.2% |
| THESEUS PHARMACEUTICALS INC | 8 | Q3 2023 | 2.3% |
View Nextech Invest Ltd.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-01 |
| 13F-HR/A | 2022-05-16 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
View Nextech Invest Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.